Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00579436 · ClinicalTrials.gov registry record · NA
Effects of Fish Oils on Inflammation and Insulin Resistance
A NA study of Insulin Resistance and Metabolic Syndrome, sponsored by Philip Kern.
- Completed
- Registry status
- NA
- Development phase
- 33
- Enrollment target
- 1
- Study location
NCT00579436 is a NA study of Insulin Resistance and Metabolic Syndrome that has completed, run by Philip Kern. The registered enrollment target is 33 participants, below the 245-participant average among 120 other Insulin Resistance trials with a reported enrollment target (87% lower). The trial reports 1 study location across 1 state.
The verdict
NCT00579436, a NA study of Insulin Resistance and Metabolic Syndrome, has completed, sponsored by Philip Kern.
- COMPLETED
- Registry status
- NA
- Development phase
- 33 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to determine whether improvement in fat and muscle metabolism after the treatment with Omacor (fish oils) provides insight into the link between obesity, fat and muscle function leading to metabolic syndrome, which is a risk factor for heart disease and diabetes.
Conditions Studied
Interventions
- DRUG placebo
- DRUG omega-3 fatty acid
Study Locations (1)
Kentucky
- University of Kentucky Medical Cener - Lexington
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 33 participants |
| Start Date | 2007-01 |
| Est. Completion | 2015-01-15 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00579436
The ClinicalTrials.gov registry entry for NCT00579436 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 33 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 245-participant average among 120 other Insulin Resistance trials with a reported enrollment target (87% lower). The listed sponsor is Philip Kern, which has 9 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Insulin Resistance appearing as the primary indexed condition, and to 2 interventions - of which placebo is the first listed.
NCT00579436 reports 1 study location spanning 1 distinct geographic area - top geographies include Kentucky.
Frequently Asked Questions
What is clinical trial NCT00579436 about?
NCT00579436 is a clinical study titled "Effects of Fish Oils on Inflammation and Insulin Resistance". The purpose of this study is to determine whether improvement in fat and muscle metabolism after the treatment with Omacor (fish oils) provides insight into the link between obesity, fat and muscle function leading to metabolic syndrome, which is a risk factor for heart disease and diabetes.
What is the current status of trial NCT00579436?
This trial is currently completed. It is a NA study. The enrollment target is 33 participants. The study started on 2007-01. Estimated completion is 2015-01-15.
What conditions does trial NCT00579436 study?
This clinical trial studies the following conditions: Insulin Resistance, Metabolic Syndrome.
What interventions are being tested in trial NCT00579436?
The interventions under investigation include: placebo (DRUG), omega-3 fatty acid (DRUG).
Who is sponsoring clinical trial NCT00579436?
This trial is sponsored by Philip Kern, which has 9 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00579436 being conducted?
This trial has 1 study location across Kentucky. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Insulin Resistance
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Metabolic Adaptations to Weight Loss With and Without Exercise
RECRUITING · NA
-
Longitudinal Multi-Omic Profiles to Reveal Mechanisms of Obesity-Mediated Insulin Resistance
RECRUITING · NA
-
Effect of Weight Loss on Intermuscular Adipose Tissue (IMAT) Signaling
RECRUITING · NA
-
Small Extracellular Vesicles and Insulin Action
RECRUITING · NA
-
Exercise Effects on Adipose Tissue Structure and Function
RECRUITING · NA
-
New Mechanisms of Obesity
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.